DXR
Daxor Corporation
1W: -4.7%
1M: -11.1%
3M: -13.7%
YTD: -23.8%
1Y: +32.3%
3Y: +27.2%
5Y: -16.1%
$10.94
-0.18 (-1.62%)
After Hours: $10.23 (-0.71, -6.44%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$55.1M
52W Range7.1-14.76
Volume33,891
Avg Volume8,128
Beta0.04
Dividend—
Analyst Ratings
Company Info
CEOMichael Richard Feldschuh
Employees37
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1983-07-25
Websitedaxor.com
109 Meco Lane
Oak Ridge, TN 37830
US
Oak Ridge, TN 37830
US
12123308500
About Daxor Corporation
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Latest News
Daxor reports FY results
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
Daxor Corporation Announces $9 Million Registered Direct Offering
Daxor (NASDAQ:DXR) Trading Down 1.4% – Here’s Why
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Feldschuh Jonathan A | P-Purchase | 18,000 | — | 2025-12-09 |
| Michel Robert J | P-Purchase | 3,000 | — | 2025-12-09 |
| Jefferies John | P-Purchase | 2,344 | — | 2025-11-12 |
| Jefferies John | 0 | — | 2025-09-30 | |
| Jefferies John | 885 | $11.30 | 2025-09-30 |